Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trine Tramm

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Breast (Edinburgh, Scotland)|July 12, 2023
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkersMelanie Machiels, Redouane Oulkadi, Trine Tramm, et al.
Breast (Edinburgh, Scotland)|February 21, 2021
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challengesOrit Kaidar-Person, Birgitte V Offersen, Liesbeth J Boersma, et al.
Plos One|December 3, 2010
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcomeSimen Myhre, Hayat Mohammed, Trine Tramm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2025
Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of viewOrit Kaidar-Person, Philip Poortmans, Birgitte Vrou Offersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 26, 2026
Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 StudyDemet Özcan, Anders Winther Mølby Nielsen, Patricia Switten Nielsen, et al.
BMC Cancer|March 14, 2026
Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trialDemet Özcan, Patricia Switten Nielsen, Jan Alsner, et al.
Oral Oncology|January 13, 2026
Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort studySebastian Søby, Danny Mortensen, Anita Gothelf, et al.
JAMA Oncology|January 17, 2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative ReviewIcro Meattini, Charlotte E Coles, Trine Tramm, et al.
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologistsTrine Tramm, Tina Di Caterino, Anne-Marie B Jylling, et al.
EJNMMI Research|March 26, 2024
Increased lesion detectability in patients with locally advanced breast cancer-A pilot study using dynamic whole-body [<sup>18</sup>F]FDG PET/CTMette Abildgaard Pedersen, André H Dias, Karin Hjorthaug, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Breast (Edinburgh, Scotland)|July 12, 2023
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkersMelanie Machiels, Redouane Oulkadi, Trine Tramm, et al.
Breast (Edinburgh, Scotland)|February 21, 2021
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challengesOrit Kaidar-Person, Birgitte V Offersen, Liesbeth J Boersma, et al.
Plos One|December 3, 2010
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcomeSimen Myhre, Hayat Mohammed, Trine Tramm, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2025
Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of viewOrit Kaidar-Person, Philip Poortmans, Birgitte Vrou Offersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 26, 2026
Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 StudyDemet Özcan, Anders Winther Mølby Nielsen, Patricia Switten Nielsen, et al.
BMC Cancer|March 14, 2026
Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trialDemet Özcan, Patricia Switten Nielsen, Jan Alsner, et al.
Oral Oncology|January 13, 2026
Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort studySebastian Søby, Danny Mortensen, Anita Gothelf, et al.
JAMA Oncology|January 17, 2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative ReviewIcro Meattini, Charlotte E Coles, Trine Tramm, et al.
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologistsTrine Tramm, Tina Di Caterino, Anne-Marie B Jylling, et al.
EJNMMI Research|March 26, 2024
Increased lesion detectability in patients with locally advanced breast cancer-A pilot study using dynamic whole-body [<sup>18</sup>F]FDG PET/CTMette Abildgaard Pedersen, André H Dias, Karin Hjorthaug, et al.
Pageof 9